Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 86Breast Neoplasms 70Prostatic Neoplasms 34Head and Neck Neoplasms 26Lung Neoplasms 24Colorectal Neoplasms 24Ovarian Neoplasms 22Uterine Cervical Neoplasms 21Endometrial Neoplasms 16Brain Neoplasms 15Rectal Neoplasms 12Pancreatic Neoplasms 11Colonic Neoplasms 11Urinary Bladder Neoplasms 9Melanoma 9Lymphoma 9Leukemia 9Depression 9Stomach Neoplasms 8Pain 8Motor Activity 8Colorectal Neoplasms, Hereditary Nonpolyposis 8Sarcoma 7Oropharyngeal Neoplasms 7Multiple Myeloma 7Hematologic Neoplasms 7COVID-19 7Vulvar Neoplasms 6Health Behavior 6Glioma 6

Interventions

Surveys and Questionnaires 1Sunitinib 1Sorafenib 1Phlebotomy 1Pancreatectomy 1Histocompatibility Testing 1Gefitinib 1Everolimus 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Blood Specimen Collection 1Biopsy, Large-Core Needle 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Adenoma, Islet Cell × Surveys and Questionnaires × Clear all
NCT03043508 2019-05-23

Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)

M.D. Anderson Cancer Center

Unknown
45 enrolled

Adenoma, Islet Cell, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡